MedPharm || طبصيدلة

The woman at greatest risk for developing breast cancer is: A. African American aged 53 years with no family history of breast cancer B. Canadian Caucasian aged 53 years with grandmother having a history of breast cancer C. Ashkenazi Jew aged 53 years who tested negative for BRCA 1 and 2 mutations D. Hispanic aged 53 years with a history of atypical hyperplasia and a sister with breast cancer E. Asian aged 53 years who had taken oral contraceptives between 20 and 30 years of age

Explain the concept of "dose intensity" in the context of chemotherapy regimens. a- Refers to the specific dosage of a single drug used in treatment b- Represents the total amount of a drug administered over the entire treatment course c- Describes the concentration of the drug in the bloodstream at peak levels d- Indicates the intensity of side effects experienced by the patient e- indicate the amount of drug delivered per unit of time, impacting treatment efficacy

Therapeutic outcomes of early breast cancer differ from those of advanced breast cancer based on treatment goals. During process of evaluating therapeutic outcomes; the goal of treating early breast cancer is a- Cure b- Improving quality of life c- Palliation d- Preventing deterioration e- None of the above

Regarding stage IV breast cancer. All of the following are true EXCEPT: a- The tumor is larger than that of the other stages b- It can NOT be cured c- It can be metastasized to the lungs d- It has a positive lymph node involvement e- Anastrozole is highly recommended to improve the quality of life.

37-year-old woman has a large mass on her left breast confirmed a diagnosis of inflammatory breast cancer, with ER negative, PR weakly positive and HER2 negative, no metastasis. The best neoadjuvant therapy for breast conserving surgery is